Nitto Denko Avecia, Inc. a provider of oligonucleotide API manufacturing, has opened a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible to clients. Detlef Rethage, president of Avecia said, “The new office, located in Kendall Square, the hotspot for oligonucleotides-based therapeutics, brings Avecia, its subsidiary Nitto Avecia Pharma Services, and all other Nitto Life Sciences activities closer to its existing pa...